Barclays initiated coverage of Avery Dennison with an Overweight rating and $250 price target Avery is a unique materials science company with a proven track record of high returns and GDP-plus growth, the analyst tells investors in a research note. The firm says that even acknowledging some radio frequency identification questions, it thinks the stock’s multi-year risk/reward is more favorable relative to its average covered company.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVY:
- Avery Dennison price target lowered to $240 from $241 at Citi
- Avery Dennison price target lowered to $252 from $254 at BMO Capital
